Forest Laboratories, Inc. (FRX) Tops Q3 EPS by 3c; Raises FY12 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts FRX Hot Sheet
Join SI Premium – FREE
Forest Laboratories, Inc. (NYSE: FRX) reported Q3 EPS of $1.04, $0.03 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.18 billion.
Forest Laboratories, Inc. sees FY2012 EPS of $3.65-$3.75, versus prior guidance of $3.60-$3.70 and the consensus of $3.68.
Forest Laboratories, Inc. sees FY2012 EPS of $3.65-$3.75, versus prior guidance of $3.60-$3.70 and the consensus of $3.68.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- ConAgra Brands (CAG) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY27 EPS Guidance
- AbbVie updates 2026 earnings guidance with Q3 R&D charges
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
